Activatable Hypoxia Magnetic Resonance Imaging for Early Stratification of Radiotherapy Response
Nanoscale Horizons · 2026
DOI: 10.1039/d6nh00371k ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanoscale Horizons, 2026. Verfasst von Mingkun Wang und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Tumor hypoxia is a major cause of radioresistance and heterogeneous outcomes in radiotherapy (RT). Noninvasive strategies capable of quantifying tumor hypoxia prior to treatment are essential for precision radiotherapy and...
Zitieren
APA
Wang, M., Liu, X., Dong, G., Chen, W., Shi, C., Zhang, X., Li, A., Zhou, Z., Wang, Y., Yang, H., & Zeng, F. (2026). Activatable Hypoxia Magnetic Resonance Imaging for Early Stratification of Radiotherapy Response. Nanoscale Horizons. https://doi.org/10.1039/d6nh00371k
Vancouver
Wang M, Liu X, Dong G, Chen W, Shi C, Zhang X, et al. Activatable Hypoxia Magnetic Resonance Imaging for Early Stratification of Radiotherapy Response. Nanoscale Horizons. 2026. doi:10.1039/d6nh00371k
BibTeX
@article{Wang2026,
author = {Wang, Mingkun and Liu, Xiaoming and Dong, Guoao and Chen, Weilin and Shi, Changrong and Zhang, Xinyi and Li, Ao and Zhou, Zijian and Wang, Yixi and Yang, Hong-Yi and Zeng, Fantian},
title = {Activatable Hypoxia Magnetic Resonance Imaging for Early Stratification of Radiotherapy Response},
journal = {Nanoscale Horizons},
year = {2026},
doi = {10.1039/d6nh00371k}
}
EUVIMED